|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/10/20 Organovo Holdings, Inc. 10-Q 12/31/19 59:6M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 570K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 24K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 24K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 23K
42: R1 Document and Entity Information HTML 75K
13: R2 Condensed Consolidated Balance Sheets HTML 94K
31: R3 Condensed Consolidated Balance Sheets HTML 29K
(Parenthetical)
47: R4 Unaudited Condensed Consolidated Statements of HTML 73K
Operations and Other Comprehensive Loss
43: R5 Unaudited Condensed Consolidated Statements of HTML 73K
Stockholders' Equity
16: R6 Unaudited Condensed Consolidated Statements of HTML 110K
Cash Flows
33: R7 Description of Business HTML 35K
49: R8 Summary of Significant Accounting Policies HTML 68K
40: R9 Stockholders' Equity HTML 271K
30: R10 Collaborative Research, Development, and License HTML 27K
Agreements
18: R11 Commitments and Contingencies HTML 28K
41: R12 Leases HTML 80K
50: R13 Concentrations HTML 24K
29: R14 Related Parties HTML 26K
17: R15 Restructuring HTML 72K
39: R16 Subsequent Events HTML 23K
48: R17 Summary of Significant Accounting Policies HTML 84K
(Policies)
32: R18 Stockholders' Equity (Tables) HTML 269K
14: R19 Leases (Tables) HTML 68K
36: R20 Restructuring (Tables) HTML 73K
56: R21 Description of Business - Additional Information HTML 65K
(Detail)
24: R22 Summary of Significant Accounting Policies - HTML 144K
Additional Information (Detail)
20: R23 Stockholders' Equity - Schedule of Stock-based HTML 29K
Compensation Expense (Detail)
35: R24 Stockholders' Equity - Stock-based Compensation HTML 36K
Expense and Valuation Information - Additional
Information (Detail)
55: R25 Stockholders' Equity - Fair Value of Employee HTML 34K
Stock Options (Detail)
23: R26 Stockholders' Equity - Fair Value of Employee HTML 21K
Stock Options (Parenthetical) (Detail)
19: R27 Stockholders' Equity - Fair Value of Employee HTML 48K
Stock Purchase Plan (Detail)
34: R28 Stockholders' Equity - Fair Value of Employee HTML 24K
Stock Purchase Plan (Parenthetical) (Detail)
57: R29 Stockholders' Equity - Preferred Stock - HTML 24K
Additional Information (Detail)
53: R30 Stockholders' Equity - Common Stock - Additional HTML 63K
Information (Detail)
44: R31 Stockholders' Equity - Summary of Company's HTML 49K
Restricted Stock Units Activity and
Performance-Based Restricted Stock Units Activity
(Detail)
11: R32 Stockholders' Equity - Restricted Stock Awards, HTML 89K
Restricted Stock Units and Performance-Based
Restricted Stock Units - Additional Information
(Detail)
27: R33 Stockholders' Equity - Summary of Stock Option HTML 55K
Activity (Detail)
54: R34 Stockholders' Equity - Stock Options and Employee HTML 54K
Stock Purchase Plan - Additional Information
(Detail)
45: R35 Stockholders' Equity - Summary of Warrant Activity HTML 46K
(Detail)
12: R36 Stockholders' Equity - Warrants - Additional HTML 21K
Information (Detail)
28: R37 Stockholders' Equity - Common Stock Reserved for HTML 38K
Future Issuance (Detail)
51: R38 Collaborative Research, Development, and License HTML 46K
Agreements - Additional Information (Detail)
46: R39 Leases - Additional Information (Details) HTML 72K
58: R40 Leases - Schedule of Impact of Adoption of ASC 842 HTML 45K
on Consolidated Balance Sheet (Details)
37: R41 Leases - Summary of Cash Flows Associated with HTML 22K
Company's Leases (Details)
21: R42 Related Parties - Additional Information (Detail) HTML 46K
26: R43 Restructuring - Additional Information (Details) HTML 37K
59: R44 Restructuring - Summary of Restructuring Charges HTML 31K
Recorded in Selling, General and Administrative
Expenses (Details)
38: R45 Restructuring - Summary of Activity and Balances HTML 36K
of Restructuring Reserve (Details)
22: R46 Subsequent Events - Additional Information HTML 24K
(Detail)
25: XML IDEA XML File -- Filing Summary XML 106K
52: EXCEL IDEA Workbook of Financial Reports XLSX 72K
5: EX-101.INS XBRL Instance -- onvo-20191231 XML 1.63M
7: EX-101.CAL XBRL Calculations -- onvo-20191231_cal XML 94K
8: EX-101.DEF XBRL Definitions -- onvo-20191231_def XML 552K
9: EX-101.LAB XBRL Labels -- onvo-20191231_lab XML 1.02M
10: EX-101.PRE XBRL Presentations -- onvo-20191231_pre XML 819K
6: EX-101.SCH XBRL Schema -- onvo-20191231 XSD 146K
15: ZIP XBRL Zipped Folder -- 0001564590-20-004042-xbrl Zip 134K
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Organovo Holdings, Inc. (the “Company”) for the period ended December 31, 2019, as filed with the Securities and Exchange Commission (the “Report”), I, Taylor Crouch, Chief Executive Officer and President and I, Craig Kussman, Chief Financial Officer of the Company hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
|
|
• |
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
• |
The information in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: February 10, 2020
|
/s/ Taylor Crouch |
|
Chief Executive Officer and President (Principal Executive Officer) |
|
/s/ Craig Kussman |
|
Chief Financial Officer (Principal Financial Officer) |
A signed original of this written statement required by Section 906 has been provided to Organovo Holdings, Inc. and will be retained by Organovo Holdings, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission, and is not to be incorporated by reference into any filing of Organovo Holdings, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 2/10/20 | None on these Dates | ||
| For Period end: | 12/31/19 | |||
| List all Filings | ||||